After its two-day meeting, the Federal Reserve announced an acceleration of tapering. Here’s why investors are responding favorably. Read More
John Persinos is the editorial director of Investing Daily, overseeing such publications as Personal Finance, Utility Forecaster, Profit Catalyst Alert, Rapier's Income Accelerator, Income Forecaster, and Marijuana Investing Daily, among others. John also writes the Mind Over Markets daily stock market recap, and he's the chief investment strategist of Marijuana Profit Alert.
John has decades of experience in the technology and political realms. He has worked as a staff editor at Inc. and Venture magazines, and written for Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, to name a few. In a career that has spanned more than 40 years, John has been diligently and prolifically covering the news and its impact on investors.
John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan (D-ND). John started his career as a daily newspaperman with The Orlando Sentinel.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
Our editorial director examines the pros and cons of cryptocurrency investing and shows you the smart way to play the crypto craze. Read More
From Hunter S. Thompson to Snoop Dogg, celebrity names (many of them infamous) are being used to market marijuana to the masses. Read More
We’re seeing record high levels of companies repurchasing their shares. Here are the pros and cons of buybacks and why you should be leery. Read More
Despite risks such as inflation, the economy is growing and stocks are rising. We examine the positives that are keeping the bull intact. Read More
Chinese developer Evergrande this week defaulted. We examine China's massive debt woes and other investment risks. Read More
Federal law enforcement officials recently told Congress that they want to make it easier for scientists to study cannabis (and even LSD). Read More
These are volatile and unnerving times, but robust corporate earnings projections should be sufficient medicine to keep stocks aloft. Read More
Remaining logical when the herd panics is always a good idea when investing, but it’s especially important during pandemic-induced selloffs. Read More
A surge of mergers and acquisitions is transforming the marijuana industry, bringing together blue-chip financiers with pot pioneers. Read More